Mercer Global Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.6M | Sell |
155,860
-5,023
| -3% | -$272K | 0.01% | 553 |
|
|
2025
Q4 | $9.45M | Buy |
160,883
+26,168
| +19% | +$1.22M | 0.01% | 503 |
|
|
2025
Q3 | $5.81M | Buy |
134,715
+17,120
| +15% | +$669K | 0.01% | 617 |
|
|
2025
Q2 | $4.76M | Sell |
117,595
-2,408
| -2% | -$92K | 0.01% | 581 |
|
|
2025
Q1 | $4.88M | Sell |
120,003
-20,084
| -14% | -$735K | 0.01% | 546 |
|
|
2024
Q4 | $4.74M | Sell |
140,087
-16,258
| -10% | -$585K | 0.01% | 549 |
|
|
2024
Q3 | $6.37M | Buy |
156,345
+8,760
| +6% | +$358K | 0.01% | 439 |
|
|
2024
Q2 | $5.79M | Buy |
147,585
+516
| +0.4% | +$21.7K | 0.02% | 417 |
|
|
2024
Q1 | $6.3M | Buy |
147,069
+16,514
| +13% | +$681K | 0.02% | 405 |
|
|
2023
Q4 | $4.84M | Sell |
130,555
-11,565
| -8% | -$415K | 0.01% | 477 |
|
|
2023
Q3 | $5.15M | Buy |
142,120
+58,022
| +69% | +$2.06M | 0.02% | 428 |
|
|
2023
Q2 | $3M | Buy |
84,098
+25,301
| +43% | +$908K | 0.01% | 600 |
|
|
2023
Q1 | $2.03M | Buy |
58,797
+12,958
| +28% | +$453K | 0.01% | 672 |
|
|
2022
Q4 | $1.61M | Buy |
45,839
+6,584
| +17% | +$219K | 0.01% | 743 |
|
|
2022
Q3 | $1.16M | Buy |
+39,255
| New | +$1.49M | 0.01% | 792 |
|
|
2022
Q2 | – | Sell |
-99,022
| Closed | -$5.39M | – | 1862 |
|
|
2022
Q1 | $5.39M | Buy |
99,022
+11,888
| +14% | +$646K | 0.03% | 366 |
|
|
2021
Q4 | $4.8M | Buy |
87,134
+37,492
| +76% | +$1.95M | 0.03% | 390 |
|
|
2021
Q3 | $2.37M | Sell |
49,642
-2,736
| -5% | -$137K | 0.02% | 554 |
|
|
2021
Q2 | $2.61M | Buy |
52,378
+5,706
| +12% | +$274K | 0.02% | 492 |
|
|
2021
Q1 | $2.08M | Sell |
46,672
-5,298
| -10% | -$240K | 0.02% | 511 |
|
|
2020
Q4 | $2.39M | Sell |
51,970
-12,689
| -20% | -$583K | 0.03% | 382 |
|
|
2020
Q3 | $3.04M | Buy |
64,659
+1,301
| +2% | +$65.2K | 0.05% | 292 |
|
|
2020
Q2 | $3.23M | Sell |
63,358
-10,734
| -14% | -$551K | 0.06% | 237 |
|
|
2020
Q1 | $3.51M | Sell |
74,092
-31,695
| -30% | -$1.69M | 0.08% | 216 |
|
|
2019
Q4 | $6.21M | Sell |
105,787
-4,987
| -5% | -$277K | 0.12% | 144 |
|
|
2019
Q3 | $5.91M | Buy |
110,774
+16,209
| +17% | +$834K | 0.14% | 133 |
|
|
2019
Q2 | $4.73M | Buy |
94,565
+4,686
| +5% | +$235K | 0.13% | 144 |
|
|
2019
Q1 | $4.7M | Buy |
+89,879
| New | +$4.49M | 0.17% | 112 |
|
Other funds holding GSK
JEST
